Specifically with regard to the current markers for EGFR inhibition therapy and known (metastatic) colorectal cancer risk factor genes KRAS, NRAS, and BRAF, no association with growth patterns was found [34–36]. This evidence concerns the gene BRAF and colorectal cancer.